Login

Davide Tinazzi (Energy) Interviewed by ItalyPost and auxiell | Davide Tinazzi - CEO of Energy SpA 00:10:00

Share On Facebook Share On Twitter

Davide Tinazzi is Chief Executive Officer at Energy SpA.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Kim Silberman from Cadiz Securities Discusses Eskom Rate Increase Impact and Future Outlook on CNBC Africa
00:10:00
Senator Rob Portman Discusses Obamacare, Health Care Reform, and Policy Alternatives
00:10:00
Bruce Mold Discusses Resolute Mining's Transition to Automated Underground Mining at Syama
00:10:00
Overview of BW's Successful Construction and Operation in Japan's Nuclear Sector
00:10:00
where it currently exists versus Where the world is headed |Peter C. Lewis,CHAIRMAN,Wharton Equity Partners
00:10:00
Thomas Ruggia is the President and CEO of Samsara Vision.
00:10:00
Ajay Nagpal: Insights from Millennium's COO on Supporting Emerging Social Entrepreneurs with Echoing Green and Brown Connect
00:10:00
"Mastering Investment Decisions in 2024: Insights with Caspar Berry | Schroders Investor Download Podcast"
00:10:00
High Gold Mining: Unearthing Value in North America
00:10:00
Danimer CEO Unveils Nature-Inspired Biodegradable Plastic Innovation | Stephen E. Croskrey - CEO of Danimer Scientific
00:10:00
Castlepoint Employee Spotlight: Kian Rahmanzadeh
00:10:00
Mike Gold on Intermedia's Strategic Growth and Market Evolution | Michael Gold, CEO, Intermedia Partners.

© 2017 - Neuhu+